Zevra Therapeutics, Inc. (ZVRA)
NASDAQ: ZVRA · Real-Time Price · USD
9.12
+0.14 (1.56%)
At close: Mar 9, 2026, 4:00 PM EDT
10.75
+1.63 (17.87%)
After-hours: Mar 9, 2026, 7:59 PM EDT
Zevra Therapeutics Market Cap
Zevra Therapeutics has a market cap or net worth of $513.43 million as of March 9, 2026. Its market cap has increased by 22.86% in one year.
Market Cap
513.43M
Enterprise Value
376.64M
1-Year Change
22.86%
Ranking
Category
Stock Price
$9.12
Market Cap Chart
Since April 16, 2015, Zevra Therapeutics's market cap has increased from $137.80M to $513.43M, an increase of 272.59%. That is a compound annual growth rate of 12.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 505.60M | 0.24% |
| Dec 31, 2025 | 504.40M | 13.30% |
| Dec 31, 2024 | 445.20M | 87.69% |
| Dec 29, 2023 | 237.20M | 49.75% |
| Dec 30, 2022 | 158.40M | -48.50% |
| Dec 31, 2021 | 307.60M | 505.51% |
| Dec 31, 2020 | 50.80M | 303.17% |
| Dec 31, 2019 | 12.60M | -73.25% |
| Dec 31, 2018 | 47.10M | -20.71% |
| Dec 29, 2017 | 59.40M | 37.50% |
| Dec 30, 2016 | 43.20M | -84.95% |
| Dec 31, 2015 | 287.00M | 108.27% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fulcrum Therapeutics | 528.81M |
| Century Therapeutics | 528.16M |
| Prothena Corporation | 528.10M |
| Relmada Therapeutics | 525.80M |
| ADC Therapeutics | 524.00M |
| CorMedix | 518.57M |
| Rigel Pharmaceuticals | 518.54M |
| Vanda Pharmaceuticals | 513.06M |